Food and Drugs Administration of the USA (FDA) has expanded the list of contraindications and side effects of Tamiflu after there appeared reports about cases of delirium and hallucinations in patients taking it.
World Health Organization recommends the influenza drug Tamiflu as the most effective treatment for bird and swine flu and several national governments have begun to create strategic stockpiles of Tamiflu in case of epidemic beginning.
Rights of Tamiflu production belong to a pharmaceutical giant Roche. 95 of 103 reports about psychiatric problems in patients taking Tamiflu were received from Japan, approximately 60% of victims are children and adolescents under the age of 17 years. In some cases, complications led to the mutilation and even suicide.
FDA warned parents about the need of particularly careful supervision for sick children receiving the drug.
There is a lack of direct evidence that the anomalous behavior of patients is provoked by the use of Tamiflu. Appropriate warnings are typed on the drug package only to completely eliminate the risk of possible complications.
